Identification
Symbol
BIO
ISIN code
FR0010095596
Exchange / Market
Euronext
Trading location
Paris
Products family
Funds
ICB
Biotechnology
Issuer website
http://www.bioalliancepharma.com
Operation
IPO date
IPO type

<p>
Global Placement and Open Price Offer</p>

IPO price
13.30 euros
IPO type
Initial Public offering
Catégorie
IPO
Operation procedure

<p>
Conditions applying to both Global Placement and Open Price Offer The first share price will be set at the end of the OPO and will take into account the demand expressed in the Global Placement. The prices of the Global Placement and the OPO are the same. The definitive price will be set on December 7th, 2005 after centralisation of the OPO and should be published by Euronext Paris in a notice that same day. The final share price may be set outside the mentioned range. The Global Placement Prior to the quotation, part of the shares will be distributed to institutional investors, within the framework of a Global Placement realised in France and abroad (excluding notably the United States of America). - Number of shares: 1,901,409 to 2,177,419 shares (approximately 90% of the offered shares before the exercise of the over-allocation option). The number of shares offered within the Global Placement may be increased if the OPO is not fully subscribed. - Underwriters: Bryan, Garnier &amp; co, Lead Manager and Bookrunner, ING Securities Bank, Lead Manager and Bookrunner, The Open Price Offer Number of shares in the OPO: 211,268 to 241,936 shares (approximately 10% of the offered shares before the exercise of the over-allocation option). The OPO is mainly open to natural persons. The number of shares offered within the Global Placement may be reduced in order to increase the OPO. However, that number of shares offered in the OPO will not exceed 15% of the total number of shares offered in the placement.</p>

Operation description
Operation calendar

<p>
- Period of the Global Placement: from November 23th, to December 7th, 2005 (12:00) - Period of the Open Price Offer: from November 23th, to December 6th, 2005 (17:00) - First quotation: December 7th, 2005 - Beginning of trading: December 8th, 2005 - From December 8th, 2005 and until December 12th, 2005 inclusive: trading of new and old shares on a single quotation line &quot;BIOALLIANCE PROMESSES&quot; under the code FR0010095596 - From December 13th, 2005: the BIOALLIANCE PHARMA shares will be quoted under the title &quot;BIOALLIANCE PHARMA&quot;, code ISIN FR0010095596 (unchanged) and mnemonic BIO (unchanged)</p>

Price range
12.40 euros – 14.20 euros
Broker to issue

<p>
&nbsp;Bryan, Garnier &amp; co<br />
ING Securities Bank (France)</p>